CELLCOM ISRAEL LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,510 ILa | -1.95% |
|
+1.68% | +1.07% |
| Mar. 12 | Cellcom Israel Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Fortissimo Capital in Talks to Buy Controlling Share of Cellcom | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,619 | 2,578 | 2,855 | 3,017 | 2,470 | 2,500 | - | - |
| Enterprise Value (EV) 1 | 1,619 | 2,578 | 2,855 | 3,017 | 2,470 | 2,500 | 2,500 | 2,500 |
| P/E ratio | -12.2 x | -27.3 x | 109 x | 19.4 x | 18.4 x | 16.4 x | 15.6 x | 14.7 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 701,401 x | - | 701,624 x | - | - | - | - |
| EV / Revenue | - | 701,401 x | - | 701,624 x | - | - | - | - |
| EV / EBITDA | - | - | - | 2,520,452 x | - | - | - | - |
| EV / FCF | - | 3,699,212 x | - | - | - | - | - | - |
| FCF Yield | - | 0% | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 147,288 | 162,775 | 163,321 | 163,433 | 165,337 | 165,561 | - | - |
| Reference price 2 | 10.99 | 15.84 | 17.48 | 18.46 | 14.94 | 15.10 | 15.10 | 15.10 |
| Announcement Date | 3/23/20 | 3/17/21 | 3/10/22 | 3/9/23 | 3/12/24 | - | - | - |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales | - | 3,676 | - | 4,300 | - | - | - | - |
| EBITDA | - | - | - | 1,197 | - | - | - | - |
| EBIT | - | 4 | - | - | - | - | - | - |
| Operating Margin | - | 0.11% | - | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
| Net income | - | - | - | 157 | - | - | - | - |
| Net margin | - | - | - | 3.65% | - | - | - | - |
| EPS 1 | -0.9000 | -0.5800 | 0.1600 | 0.9500 | 0.8100 | 0.9220 | 0.9650 | 1.025 |
| Free Cash Flow | - | 697 | - | - | - | - | - | - |
| FCF margin | - | 18.96% | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/23/20 | 3/17/21 | 3/10/22 | 3/9/23 | 3/12/24 | - | - | - |
1ILS
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1,069 | 1,061 | - | 1,070 |
| EBITDA 1 | - | 298 | 297 | - | 321 |
| EBIT 1 | - | - | - | - | 50 |
| Operating Margin | - | - | - | - | 4.67% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income 1 | 28 | 39 | 49 | 43 | 5 |
| Net margin | - | 3.65% | 4.62% | - | 0.47% |
| EPS 2 | 0.1700 | - | - | 0.2600 | 0.0300 |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 5/18/22 | 8/10/22 | 3/9/23 | 5/17/23 | 8/10/23 |
1ILS in Million2ILS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2,265 | 2,601 | 2,810 | 2,751 | 2,694 | 2,493 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 4.339 x | 5.511 x | 6.755 x | 4.219 x | 3.2 x | 2.882 x |
| Free Cash Flow 1 | 102 | 379 | 587 | 334 | 477 | 388 |
| ROE (net income / shareholders' equity) | -4.11% | -6% | -9.03% | 1.42% | 7.8% | 6.14% |
| ROA (Net income/ Total Assets) | 0.97% | 0.33% | -0.31% | 2.09% | 3.76% | 3.24% |
| Assets 1 | -6,367 | -32,190 | 55,646 | 1,295 | 4,177 | 4,136 |
| Book Value Per Share 2 | 14.40 | 12.80 | 11.60 | 9.550 | 12.70 | 13.90 |
| Cash Flow per Share 2 | 10.30 | 6.830 | 4.420 | 3.200 | 4.680 | 2.900 |
| Capex 1 | 356 | 324 | 296 | 366 | 335 | 427 |
| Capex / Sales | 9.65% | 8.74% | 8.05% | 8.93% | 7.79% | 9.71% |
| Announcement Date | 3/18/19 | 3/23/20 | 3/17/21 | 3/10/22 | 3/9/23 | 3/12/24 |
1ILS in Million2ILS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
15.1
ILS
Average target price
19
ILS
Spread / Average Target
+25.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.07% | 656M | |
| +2.26% | 193B | |
| -0.18% | 120B | |
| +23.66% | 72.46B | |
| -2.36% | 57.97B | |
| +24.90% | 23.92B | |
| +0.76% | 23.3B | |
| +9.95% | 16.07B | |
| -10.14% | 15.66B | |
| +4.97% | 9.6B |
- Stock Market
- Equities
- CEL Stock
- Financials Cellcom Israel Ltd.
